Jozef Madzo to Hematologic Neoplasms
This is a "connection" page, showing publications Jozef Madzo has written about Hematologic Neoplasms.
Connection Strength
0.442
-
Perturbations of 5-hydroxymethylcytosine patterning in hematologic malignancies. Semin Hematol. 2013 Jan; 50(1):61-9.
Score: 0.344
-
A phase I and pharmacodynamic study of the histone deacetylase inhibitor belinostat plus azacitidine in advanced myeloid neoplasia. Invest New Drugs. 2015 Apr; 33(2):371-9.
Score: 0.098